The national incidence of PML in Sweden, 1988-2013.

Neurology

From the Department of Clinical Neuroscience, Division of Neurology (E.I., R.H., T.O., L.B.), Neuroimmunology Unit, Center for Molecular Medicine, Department of Clinical Neuroscience (T.O., L.B.), and Center for Pharmacoepidemiology (S. Burkill, S. Bahmanyar, C.B.) and Clinical Epidemiology Unit (M.F., S.M.), Department of Medicine, Solna, Karolinska Institutet, Stockholm; Clinical Epidemiology and Biostatistics (S.M.), School of Medical Sciences, Örebro University, Sweden; and Department of Epidemiology and Public Health (S.M.), University College London, UK.

Published: February 2018

Objective: To investigate the incidence of progressive multifocal leukoencephalopathy (PML) and patient characteristics in Sweden between 1988 and 2013.

Methods: All PML diagnoses in Sweden between 1988 and 2013 were identified in the National Patient Register. Information to validate the diagnosis and patient characteristics was obtained from medical records.

Results: Medical record review classified 108 out of 250 patients (43%) as definite (n = 84), probable (n = 4), or possible (n = 20) PML according to diagnostic criteria. Accurate diagnoses were more common in records obtained from neurology departments (82% of patients seen in neurology departments) compared with other departments (31%) ( < 0.001). The incidence of PML increased from a largely stable level at 0.026 (95% confidence interval [CI] 0.021-0.031) per 100,000 individuals per year during 1988-2010 to 0.11 (95% CI 083-0.137) during 2011-2013, during which time there was a notable increase ( < 0.001). Hematologic malignancies (n = 34), HIV/AIDS (n = 33), and autoimmune disease (n = 23) were the most common underlying diseases. Treatment with a monoclonal antibody prior to PML diagnosis was identified in 26 patients.

Conclusion: An increased incidence of PML in Sweden was observed and coincided with the prior use of monoclonal antibody treatment. The high level of misdiagnosis emphasizes the importance of immediate contact with a neurology center upon suspicion of PML.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818018PMC
http://dx.doi.org/10.1212/WNL.0000000000004926DOI Listing

Publication Analysis

Top Keywords

incidence pml
12
pml
8
pml sweden
8
patient characteristics
8
sweden 1988
8
neurology departments
8
monoclonal antibody
8
national incidence
4
sweden
4
sweden 1988-2013
4

Similar Publications

Ferroptosis plays a role in tumorigenesis by affecting lipid peroxidation and metabolic pathways; however, its prognostic or therapeutic relevance in pancreatic adenocarcinoma (PAAD) remains poorly understood. In this study, we developed a prognostic ferroptosis-related gene (FRG)-based risk model using cohorts of The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC), proposing plausible therapeutics. Differentially expressed FRGs between tumors from TCGA-PAAD and normal pancreatic tissues from Genotype-Tissue Expression were analyzed to construct a prognostic risk model using univariate and multivariate Cox regression and LASSO analyses.

View Article and Find Full Text PDF

Cryo-EM structure of PML RBCC dimer reveals CC-mediated octopus-like nuclear body assembly mechanism.

Cell Discov

November 2024

Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

Article Synopsis
  • The study presents the cryo-electron microscopy structure of the PML dimer, revealing key details about its composition and the significant folding events that facilitate dimerization.
  • Researchers identified a novel "octopus-like" mechanism for NB assembly, where helices from different PML dimers interact in an anti-parallel manner to form a larger membrane-less organelle.
View Article and Find Full Text PDF

Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case series.

Mult Scler Relat Disord

December 2024

Division of Pharmacovigilance I, Office of Surveillance and Epidemiology (DC, TK, VC, AB), Center for Drug Evaluation and Research, U.S. Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Background: Risk factors for progressive multifocal leukoencephalopathy (PML) associated with sphingosine-1-phosphate receptor (S1PR) modulators are not as well-characterized as for natalizumab. We characterized S1PR modulator-associated PML cases and risk factors for PML using spontaneous adverse event reports.

Methods: We reviewed case reports from the FDA Adverse Event Reporting System database and the medical literature.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the presence of JC virus in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) and examined its relationship with vitamin D levels, highlighting the documented link between vitamin D deficiency and viral infections in autoimmune diseases.
  • - Researchers collected urine and serum samples from 50 patients, finding that 34% tested positive for JC virus DNA, with a notable 38.7% positivity in SLE cases; vitamin D levels were significantly lower in SLE patients with the virus.
  • - The findings suggest a strong correlation between JC virus detection and vitamin D deficiency, leading to the recommendation that both should be monitored in RA and SLE patients before initiating treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!